Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
- PMID: 34854415
- PMCID: PMC8641748
- DOI: 10.4103/ijp.ijp_508_21
Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
Conflict of interest statement
None
Similar articles
-
Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course.Expert Rev Anti Infect Ther. 2021 Apr;19(4):413-417. doi: 10.1080/14787210.2021.1828062. Epub 2020 Oct 7. Expert Rev Anti Infect Ther. 2021. PMID: 32981388 No abstract available.
-
Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges.Drug Discov Today. 2020 Oct;25(10):1786-1792. doi: 10.1016/j.drudis.2020.06.030. Epub 2020 Jul 3. Drug Discov Today. 2020. PMID: 32629169 Free PMC article. Review.
-
Protecting healthcare workers: A critical part of the COVID-19 response.S Afr Med J. 2020 Oct 23;110(12):1154-1155. doi: 10.7196/SAMJ.2020.v110i12.15048. S Afr Med J. 2020. PMID: 33403955 No abstract available.
-
Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers.J Antimicrob Chemother. 2021 Feb 11;76(3):827-829. doi: 10.1093/jac/dkaa477. J Antimicrob Chemother. 2021. PMID: 33219675 Free PMC article. No abstract available.
-
Occupational Health Update: Approach to Evaluation of Health Care Personnel and Preexposure Prophylaxis.Infect Dis Clin North Am. 2021 Sep;35(3):717-734. doi: 10.1016/j.idc.2021.04.008. Infect Dis Clin North Am. 2021. PMID: 34362540 Free PMC article. Review.
References
-
- Advisory on the Use of Hydroxychloroquine – The National Task Force for COVID-19 Constituted by Indian Council of Medical Research Recommends the Use of Hydroxychloroquine – MoHFW. 2020 March 22;
-
- Hydroxychloroquine Side Effects Medically Reviewed by Drugs.com. [Last updated on 2020 Apr 26]. Available from: www.sakraworldhospital.com .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical